Stem cell-derived motor neurons (MNs) are increasingly utilized for modeling disease in vitro and for developing cellular replacement strategies for spinal cord injury and diseases such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). Human embryonic stem cell (hESC) differentiation into MNs, which involves retinoic acid (RA) and activation of the sonic hedgehog (SHH) pathway is inefficient and requires up to 60 days to develop MNs with electrophysiological properties. This prolonged differentiation process has hampered the use of hESCs, in particular for high-throughput screening. We evaluated the MN gene expression profile of RA/ SHH-differentiated hESCs to identify rate-limiting factors involved in MN development. Based on this analysis, we developed an adenoviral gene delivery system encoding for MN inducing transcription factors: neurogenin 2 (Ngn2), islet-1 (Isl-1), and LIM/homeobox protein 3 (Lhx3). Strikingly, delivery of these factors induced functional MNs with mature electrophysiological properties, 11-days after gene delivery, with >60-70% efficiency from hESCs and human induced pluripotent stem cells (hiPSCs). This directed programming approach significantly reduces the time required to generate electrophysiologically-active MNs by approximately 30 days in comparison to conventional differentiation techniques. Our results further exemplify the potential to use transcriptional coding for rapid and efficient production of defined cell types from hESCs and hiPSCs.
IntroductIon
Recent progress in cell-based modeling using human embryonic stem cell (hESC) and induced pluripotent stem cell-(iPSC)-derived motor neurons (MNs) has opened new opportunities to understand the development of the motor system as well as MN disease. MNs are a highly specialized class of neurons that reside in the spinal cord and project axons in organized and discrete patterns to muscles to control their activity. The most prominent MN diseases are spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), in which MNs perish in the disease. In the case of SMA, the genetic deficit of reduced SMN levels is known. Indeed gene delivery of SMN in a transgenic model of SMA results in prolonged survival and motor rescue, indicating that methods to increase SMN levels in MNs may be therapeutic. [1] [2] [3] [4] Stem cell-derived MNs have been derived from iPSCs from a SMA patient, providing a new population of cells for drug and therapeutic screens. 5 In addition, stem cell-based therapies have also demonstrated therapeutic potential in SMA and spinal cord injury. For example, studies have reported that transplanting MN progenitor cells into the spinal cords of SMA mice or into a spinal cord injured rat model partially restores motor decline. 6, 7 MNs have also been extensively utilized to study ALS and screen potential therapeutic compounds, [8] [9] [10] [11] [12] [13] thereby demonstrating the requirements for generating large numbers of MNs.
To generate large numbers of spinal MNs for use in in vitrobased screens and transplantation studies, neuromuscular researchers have taken advantage of the propensity of mouse ESCs to efficiently differentiate into this cell type. However, progress repeating these studies with hESCs has been slow due to the low efficiency of MN production and tedious, time-consuming culture conditions. The current procedures for generating MNs involve embryoid body formation in serum-free media and subsequent neural rosette formation in the presence of retinoic acid (RA) and sonic hedgehog (SHH), which function to caudalize and ventralize MN progenitors, 14, 15 respectively. Neurotrophic factors are then added to the medium for further maturation and to aid in cell survival. The entire differentiation process requires up to 2 months to generate MNs, which are electrophysiologically-active, with 10-40% efficiency. [16] [17] [18] [19] [20] [21] To gain insight into the barriers to MN differentiation, we evaluated the gene expression profile of MN codes in RA/SHH-treated cells temporally to determine which factors were rate-limiting in the process. After identifying these rate-limiting factors, we utilized an adenoviral gene delivery strategy to rapidly induce expression of MN codes: neurogenin 2 (NGN2), islet-1 (ISL-1), and LIM/homeobox protein 3 (LHX3) in both hES and hiPS cells. Our differentiation strategy to generate induced MNs from human pluripotent stem cells could be utilized for in vitro MN disease modeling platforms or as a potential source for cell-based therapies.
results rA/sHH induction of Mns from hescs requires a long differentiation and maturation period
For our initial studies, we utilized the HSF-6 hESC cell line, which was confirmed to have a normal karyotype throughout the course of these studies (Supplementary Figure S1) . In addition, these cells expressed high levels of alkaline phosphatase and transcription factors involved in pluripotency such as REX1, OCT3/4, NANOG, and SOX2, as assessed by immunohistochemistry and reverse transcriptase-PCR (RT-PCR) ( Supplementary  Figure S2a-c) . This line also expressed a cell surface marker unique to hESCs, SSEA4, as shown by immunocytochemical analysis (Supplementary Figure S2c) , demonstrating that our cells expressed markers for bona fide pluripotent stem cells. To confirm that the HSF-6 cell line could produce MNs, we utilized the prototypical methods of ectopically administering RA and SHH to signal MN development pathways, 16, 18, 22 (Figure 1a-b) . The HSF6-hESCs could be induced into a neuroectodermal fate, as previously described, 22, 23 with >70% of cells positive for neural progenitor cell (NPC) markers PSA-NCAM and OTX2 (Supplementary Figure S3 ). We then evaluated the MN gene expression profile by semi-quantitative RT-PCR to characterize the timing for MN activation (Figure 1c ). Following addition of RA and SHH to embryoid body cultures, we analyzed the transcriptional program that induces MN formation (Figure 1b) temporally over 30 days by semi-quantitative RT-PCR (Figure 1c) . In proliferating hESCs, no neuronal specifying factors were present in our cultures, suggesting a homogeneous population of undifferentiated cells. At day 13 of differentiation, we observed expression of early MN-specifying factors, PAX6 and OLIG2 as well as ISL-1 and NEUROD (Figure 1c ). Immunocytochemical analysis also confirmed the expression of the former three markers (Supplementary Figure S3 ). Expression of all MN-specifying genes was evident at day 20 and day 30, including strong expression of LHX3, ISL-1, and HB9 (Figure 1c) . Twenty days after RA/ SHH, choline acetyltransferase (CHAT) expression appeared and increased at day 30. Immunohistochemistry confirmed the expression of endogenous HB9, LHX3, ISL-1, and CHAT, indicating that these cells were indeed expressing prototypical markers of MNs (Figure 1d, Supplementary Figure S3 ). Quantification of HB9 + and CHAT + cells showed ~30% of total cells were indeed mature MNs, an efficiency similar to prior reports of hESC differentiation into MNs. [17] [18] [19] In addition, the hESC-derived MNs expressed SMI31, a nonphosphoryated neurofilament as well as HOXC6, demonstrating cervical MN identity, as expected (Figure 1d ). 17 Collectively, these results exhibit a slow maturation process of RA/ SHH-induced cells into a MN phenotype.
To determine whether the neurons in our cultures, which expressed mature MN markers, were indeed functionally mature, we analyzed their electrophysiological properties to test whether they could fire action potentials. Specifically, we utilized whole-cell perforated patch recording techniques to determine whether they developed the fast inactivating sodium currents and action potentials indicative of mature MNs. 24 To easily identify MNs in live cultures, a previously reported lentivirus reporter 13 neuritic extensions (Figure 1e,g) . We first evaluated the electrophysiological properties of our differentiated MN cultures at day 28, an approximate time point in which we observed high expression levels of HB9 and CHAT. Interestingly, all six recorded MNs at this time point, which had been cultured on astrocytes for an additional 4 days in the presence of neurotrophic factors for further maturation 25 were not electrophysiologically mature, despite expressing all of the phenotypic markers for a MN, as no patchclamped Hb9-RFP+ MN fired action potentials (Figure 1e-f,  Figure 2a ). This observation suggested additional maturation was required to induce the electrophysiological machinery proteins required for MNs to fire action potentials. Therefore, we cocultured these MNs for an additional 2 weeks on human astrocytes in the presence of RA/SHH and neurotrophic factors. At 42 days post RA/SHH treatment, a total of four Hb9::RFP-positive MNs were patch clamped in culture (Figure 1g ) and a current step protocol recorded fast sodium currents within all of these MNs (Figures 1h  and 2a ). In addition, upon electrical stimulation, patch-clamped Hb9-RFP+ MNs fired action potentials (Figure 1i) , with strong peak sodium currents of approximately −700 pA (Figure 1j ). All of these results demonstrate that hESCs require up to 52 days under differentiating conditions for complete functional maturation into a MN. [16] [17] [18] [19] [20] 
Gene delivery of Mn-specifying transcription factors to hescs results in rapid and efficient generation of Mns
To overcome these barriers related to inefficient and timeintensive MN differentiation from hESCs, we hypothesized that delivery of key MN-specifying transcription factors could rapidly facilitate their differentiation to MNs at a higher efficiency compared to the conventional RA/SHH approach. Based on our temporal gene expression analysis, which identified rate-limiting transcription factors when hESCs were differentiated to MNs upon RA/SHH exposure, we cloned three key MN-specifying genes -Ngn2, Isl-1, and Lhx3. Previous reports have underscored the essential roles of these factors for proper MN development. Specifically, a combinatorial expression of LIM homeodomain transcription factors, Lhx3 and Isl-1, together with the expression of the pro-neural gene, Ngn2, have been shown critical factors to induce MN specification during development. [26] [27] [28] [29] Thus, we utilized these factors to efficiently delivery Ngn2, Isl-1, and Lhx3 to our hESC-derived NPCs. We chose adenoviral vectors because of their high infectivity and rapid expression of multiple transgenes within NPCs. Immunohistochemistry revealed that these viruses were capable of infecting hESC-derived NPCs at percentage levels greater than 95% and mediating expression of their respective transcription factor (Supplementary Figure  S4) . Based on this analysis, our adenoviral delivery approach targeted ~85% of cells in culture. We next tested whether these factors could accelerate the differentiation of our hESC-derived NPCs into MNs with greater efficiency compared solely to utilizing RA/SHH-mediated differentiation (Figure 2a,b) . hESCs were induced into EBs, allowed to adhere to poly-ornithine and laminin-coated dishes, and then differentiated for 10 days into an NPC phenotype. Neural rosette structures were subsequently dissociated and then infected with our cocktail of viruses encoding Ngn2, Isl-1, and Lhx3, and hereafter referred to as N.I.L., at a multiplicity of infectivity of 100. We infected cells at two time points (day 0 and day 4 post NPC differentiation) to increase the efficiency and longevity of expression. In addition, media were supplemented during the differentiation procedure with MN factors including RA, SHH, forskolin, and B27 supplement (Figure 2b) . Eleven days following infection, we stained cells for phenotypic markers of MNs. At this differentiation stage, cells stained positive for HB9 and CHAT, suggesting that the N.I.L. transcription factors were indeed increasing the rate of MN differentiation within these cells (Figure 2c) . Nontransduced control hESC-derived NPCs incubated only with RA/SHH for 11 days showed no HB9 or CHAT immunostaining (Figure 2c) , which is also in agreement with our RT-PCR analysis of temporal gene transcription factor induction during MN differentiation with RA/SHH (Figure 1c) . To test whether the N.I.L. transcription factors were capable of MN-induced differentiation without any extrinsic neuralizing factors such as RA or SHH, hESC-derived NPCs were infected with N.I.L. and incubated only with B27 supplement to aid in their survival. Without these additional factors, the N.I.L. transcription factors were unable to induce the mature MNs markers, HB9 and CHAT, by this approach, suggesting that the caudalizing effects of RA and ventralizing functions of SHH activate alternate gene expression profiles which are essential for MN differentiation. To verify whether the N.I.L. transcription factors could efficiently direct MN differentiation from an alternative hESC line, we utilized the HuES-3 line, which had been previously engineered with an Hb9::GFP reporter. 12 We utilized the same differentiation protocol as described above, and after 11 days of differentiation, we were able to detect GFP expression within 55% of the cells, demonstrating these cells were efficiently being instructed towards a MN fate (Figure 2d) . To determine the efficiency of the N.I.L.-directed differentiation approach, we quantified the total number of cells coexpressing HB9 and CHAT. Strikingly, at this early time point, we found that 50 ± 4.5% of our differentiated cells were HB9/CHAT colabeled, indicating that this approach resulted in rapid and efficient generation of MNs (Figure 2e) . Quantification of MNs generated from the HSF-6 cell line showed 62 ± 2.5% were HB9/CHAT colabeled (Figure 2e) . Collectively, these results show that MNs can be efficiently and rapidly differentiated from two independent hESC lines by the N.I.L. transcription factor code.
n.I.l. induces predominately cervical and thoracic Mn subtypes from hescs
As hundreds of distinct MN subtypes exist throughout the length of the spinal cord, each responsible for controlling specific muscle groups, we next wanted to identify the MN subtypes that were generated from our N.I.L. induced cells. For this analysis, we applied quantitative PCR to analyze expression of members of the HOX family of transcription factors, 30-33 that dictate cervical, thoracic and lumbar segmental identity phenotypes. Consistent with prior results, 17, 18 the default MN phenotype from RA/SHH differentiation is of a cervical phenotype, and our HOX profiling confirmed high expression of cervical markers, including HOXC6, A7, B7, C8, and D8, with low levels of thoracic HOX gene expression and little to no lumbar HOX genes expressed (Figure 2f) . Also as anticipated, the N.I.L. induced cells expressed a very similar profile of HOX gene expression as RA/SHH treated cells, thereby confirming that similar MN subtypes can be generated either from our directed transcription factor based approach or by the conventional RA/SHH treatment protocol (Figure 2f) .
n.I.l.-induced Mns form neuromuscular junctions in vitro
To further evaluate the functional maturity of the induced MNs, we tested whether these cells could form neuromuscular junctions when cocultured with differentiated C2C12-derived myotubes, which were confirmed to be expressing the mature myotube marker α-actinin (Figure 2g) . Within the cocultures, we detected the synaptic marker, synaptic vesicle protein 2, colocalized with TUJ1-positive stained MN axons (Figure 2g ). In addition, motor axons colocalizing with acetylcholine receptors on the myotubes were detected with rhodamine-conjugated α-bungarotoxin (Figure 2g) , further indicating that the MNs were capable of forming neuromuscular junctions.
n.I.l.-induced Mns acquire electrophysiological properties in a rapid time frame
We next evaluated the functional maturity of the MNs by measuring their electrophysiological properties 11 days post-transduction with the N.I.L. cocktail. To visualize MNs, we infected cells with the previously described lentivirus containing an Hb9::RFP reporter and were then transferred to a layer of astrocytes for an additional 4 days before electrophysiological measurements were performed. A total of 10 RFP-positive MNs, differentiated from the HSF-6 cell line, were patch-clamped (Figure 3a) , and electrophysiological measurements demonstrated strong sodium currents (Figure 3b) , indicative of MN electrophysiological properties in all recorded MNs. Sodium channel currents could also be blocked by administration of 500 nmol/l tetrodotoxin (Figure 3c) , further demonstrating the specificity of sodium current channel measurements. In addition, the MNs demonstrated action potentials upon electrical stimulation, indicating their functional maturity (Figure 3d) . Sodium current were measured at approximately −800 pA (Figure 3e) , with the additional capacity for strong spontaneous activity (Figure 3f) . Collectively, these results demonstrate 
n.I.l. induces Mns rapidly and efficiently from hiPscs
Given the success of using N.I.L. on hESCs for rapidly and efficiently generating electrophysiologically-competent MNs, we next planned to determine whether the same approach could be utilized to generate MNs from human induced pluripotent stem cells (hiPSCs). Numerous reports have demonstrated that hiPSCs can be derived from multiple cell types utilizing various transcription factor cocktail combinations. [34] [35] [36] [37] [38] [39] [40] [41] We derived a line of hiPSCs from human fibroblasts using retroviral vectors expressing the four Yamanaka factors (OCT3/4, KLF-4, SOX2, and c-MYC) 42 (Figure 4a) . The hiPSCs were stained with LIN28, OCT3/4, SOX2, TRA-1-60, and NANOG to confirm that they expressed pluripotent characteristics (Figure 4a) . These cells were then exposed to the same protocol that we used on hESCs and described in Figure 2b . Similar to the previously described protocol for the N.I.L. induction of MNs, cells were transduced with adenoviruses expressing N.I.L. and evaluated 11 days later for MN markers. The cells exhibited robust MN differentiation, with 72 ± 3.4% of the cells colabeled with HB9 and CHAT (Figure 4b) . Previous studies have shown that iPS lines could vary in their ability to differentiate into mature cell types. 43 Therefore, we tested two additional iPS lines for their ability to become efficiently differentiated into MNs utilizing our N.I.L. induction strategy. 44 Similar to our previous results, we were able to achieve similar MN differentiation efficiencies within iPS lines 4 and 5 showing 59 ± 4.2% and 49 ± 3.3% colabeling with HB9 and CHAT, respectively (Supplementary Figure  S5, Figure 4b) . Consistent with our previous results on hESC differentiation into MNs with RA/SHH, nontransduced control cells did not stain positive for HB9 or CHAT at this early time point in differentiation. These results further exemplify the utility of the N.I.L directed programming approach on multiple hiPS cell lines showing highly efficient and rapid generation of MNs (Figure 4b) .
dIscussIon
Pluripotent cells have proven to be an invaluable stem cell source for deriving MNs. However, generating MNs is time intensive and current approaches yield 10-40% MN differentiation along with a heterogeneous population of neuronal and non-neuronal cells. [16] [17] [18] [19] [20] [21] In part, this heterogeneity is caused by the way in which RA and SHH impart neuronal diversity within the embryonic spinal cord. 45 To more accurately and efficiently guide hESCs into MNs, we utilized critical MN-specifying transcription factors that act downstream of RA/SHH signaling. 29 Our results demonstrate that MN-specifying transcription factors are capable of producing functional MNs in a rapid and efficient manner. A future direction for this technology would be to program alternate neuronal types that exist throughout the CNS. Indeed, recent work has shown that delivery of a critical transcription factor, Lmx1a, to hES cells can direct their differentiation into mesencephalic dopaminergic neurons. 46 In addition, it may be possible to use transcription factor codes to generate alternate MN subtype fates such as those that innervate limb muscles. Although we have not observed any untoward effects of sustained expression of these factors within MNs, it will be of interest to determine whether the MN genetic program is retained after silencing viral-mediated transcription factor expression postdifferentiation. Furthermore, we have observed that N.I.L.-directed MNs could survive up to 6 weeks in culture demonstrating their high applicability as a drug screening tool. MNs have been increasingly utilized to model neurodegenerative diseases in vitro such as SMA and ALS. 5, [8] [9] [10] [11] [12] [13] For example, Ebert et al. demonstrated that MNs differentiated from iPS cells, which were derived from an SMA patient, showed that SMA MNs exhibited shortened neurite extensions and decreased survival in culture compared to healthy MNs. 5 Additional reports modeling ALS in vitro have exemplified the susceptibility of MNs to ALS-derived astrocytes. [8] [9] [10] [11] [12] [13] Although ALS patient-derived MNs have been generated through iPS cell technology, 47, 48 no report has documented any defect in these MNs. To overcome the technical challenges of generating MNs from large numbers of iPS lines from patients with MN disease, a more rapid and efficient method of MN differentiation would be highly invaluable to stem cell biologists over currently available techniques. Our induced MN differentiation method from either hES or iPS cells bypasses these technical constraints of MN differentiation by generating a large supply of these cells within a rapid and accelerated time frame. We envision this technology would be highly applicable for drug screening platforms for MN disease such as SMA or ALS. Pluripotent stem cell lines could be engineered with an Hb9::GFP or Hb9::luciferase reporter system for monitoring and quantification purposes during the drug screening process. In addition, toxicology studies could also be performed on highly enriched MNs to test for candidate drug targets.
In sum, this transcriptional coding strategy allows for the generation of functional MNs with characteristic electrophysiological properties at high efficiency within ~11 days from hESCs or hiP-SCs, a strategy that should prove valuable to those studying basic MN biology in vitro, developing screening assays for MN disease, or advancing applications in regenerative medicine.
MAterIAls And MetHods
Cell culture. The HSF-6 hESC line (P65) was obtained from the National Stem Cell Bank (NSCB) and was cultured and passaged on irradiated primary mouse embryonic fibroblasts (Millipore, Billerica, MA) as previously described. 49 hiPSCs were cultured similarly to hESCs. Human iPS lines, iPS-4 and iPS-5, were obtained from Children's Hospital Boston Stem Cell Program, George Q. Daley's laboratory. The HuES-3 Hb9::GFP cell line was a kind gift from Kevin Eggan (Harvard University, Cambridge, MA).
Adenoviral and lentiviral constructs. The AdEasy Adenoviral Vector
System (Stratagene, La Jolla, CA) was utilized to construct adenoviruses for the mouse Lhx3, Isl1, and Ngn2 genes. All cDNAs corresponding to the coding regions of these genes were subcloned into the BamHI and Xho I sites of the pShuttle-CMV adenoviral vector, and all subsequent steps were performed according to the manufacturer's instructions using human 293 cells for viral propagation. Viral titers were between 10 11 and 10 12 viral particles/ml, as determined by the TCID 50 assay.
A lentiviral reporter construct driving RFP under the control of the Hb9 promoter (kind gift of Sam Pfaff, Carol Marchetto, and Fred Gage) was utilized to identify MNs. Lentivirus, pseudotyped with vesicular stomatis virus glycoprotein, was produced by quadruple transfection in HEK-293 cells, as previously described. 50 hiPSC generation. pMXs retroviral vectors (Addgene, Cambridge, MA) encoding OCT3/4, SOX2, KLF-4, and c-MYC were transfected using the CaCl 2 method separately with CMV-GP and VSVG plasmids into human embryonic kidney carcinoma 293 cells (HEK-293) to produce retroviruses. Forty-eight hours postinfection, supernatant was collected, mixed, and filtered through a 0.22-micron filter and supplemented with polybrene at 5 µg/ml. 60,000 normal fibroblasts (Coriell, Camden, NJ) were infected with retroviruses on a 10 cm 2 tissue culture plate. Media was changed to Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and cells were allowed to grow for 1 week until media was changed to hESC media supplemented with the rho kinase inhibitor, Y-27632 (Calbiochem, Gibbston, NJ). Supplementary Table S1 .
Karyotyping

MN differentiation.
To induce MN differentiation, hESC or iPSC colonies were first removed from a mouse feeder layer with 1 mg/ml collagenase IV. Colonies were then resuspended in Dulbecco's modified Eagle's medium/ F12 supplemented with 1% N2 and 10% knockout serum (Invitrogen, Carlsbad, CA), and plated within a Petri dish to induce embryoid body formation for the first 2 days. After 2 days of incubation, serum-free media was utilized as described above without 10% knockout serum for an additional 2 days. After 4 days of differentiation, EBs were then allowed to attach as distinct noncontacting colonies to polyornithine/laminin coated dishes for an additional 6 days to induce the formation of neural rosettes. Neural rosettes were then manually removed by a small pipettor, dissociated with accutase (Invitrogen), plated on poly-ornithine/laminin coated dishes, and then treated either with RA (2 µmol/l) and SHH (500 ng/ml), for conventional MN differentiation.
N.I.L.-induced MN differentiation.
NPCs were differentiated from hESCs or iPSCs by the same protocol as described above. After 10 days of differentiation into neural rosettes containing NPCs, neural rosettes were manually removed with a pipettor, dissociated, and plated on poly-ornithine/ laminin coated dishes as described above. After 24 hours, NPCs were infected with N.I.L., which is considered day 1 on the differentiation timeline (Figure 2a-b ) (multiplicity of infection = 100), and supplemented with RA (2 µmol/l), forskolin (5 µmol/l), SHH (500 ng/ml), and B27 (0.2%). On day 4, NPCs were infected an additional time at a similar multiplicity of infection and supplemented with the same factors as described above.
Myotube coculture experiments. C2C12 cells were differentiated in 10% horse serum to induce myotube formation. MNs were then plated to the myotube monolayer and showed the neuromuscular synapses within 1 week of coculture.
Immunocytochemistry and alkaline phosphatase activity staining. Cells were stained with the antibodies shown in Supplementary Table S1 . All images were captured using a Zeiss LSM510-META confocal laser-scanning microscope (Zeiss, Thornwood, NY). Staining for alkaline phosphatase activity was performed using the alkaline phosphatase activity kit (Millipore).
Electrophysiology recording.
Whole-cell patch recordings were performed from hESC-derived MNs that express Hb9::RFP. The recording micropipettes were pulled to have tip resistance of 2-4 MΩ when filled with an internal solution (115 mmol/l K-gluconate, 4 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 20 mmol/l HEPES, and 0.5 mmol/l EGTA, pH 7.3) and placed in a bath solution (115 mmol/l NaCl, 2 mmol/l KCl, 10 mmol/l HEPES, 3 mmol/l CaCl 2 , 10 mmol/l glucose, and 1.5 mmol/l MgCl 2 , pH 7.3). Recordings were made using a EPC10 amplifier (HEKA Instruments, Southboro, MA). Signals were filtered at 3 kHz and sampled at 20 kHz. The whole-cell capacitance was fully compensated, whereas the series resistance was uncompensated but monitored during the experiment by the amplitude of the capacitive current in response to a 5-mV pulse. For current-clamp recordings, cells were either held at the level without current injection to observe resting membrane potential and spontaneous firing or held at −60 ~ −70 mV level through current injection prior to the current step protocol. For voltageclamp recordings, cells were clamped at −70 mV before the voltage step protocol was performed. All recordings were performed at room temperature. suPPleMentArY MAterIAl Figure S1 . HSF-6 hESCs show a normal 46XX karyotype. Figure S2 . The HSF-6 hESC line shows markers of pluripotency. Figure S3 . HSF-6 hESCs transit through progenitor cell intermediates towards a MN fate. Figure S4 . Adenoviral transcription factors Ngn2, Isl-1, and Lhx3 can infect hESC-derived NPCs. Figure S5 . N.I.L.-induced MNs express HB9 and CHAT, and are colocalized in the same cells merged with the nuclear dye, DAPI in iPS lines 4 and 5. Table S1 . All antibodies and sequences of primers utilized in this study.
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